Emilie Stern

Emilie Stern

Auto-generated profile, based on publicly available information

Emilie Stern

Université Paris Cité, Laboratoire de Psychopathologie et Processus de Santé, F-92100, Boulogne-Billancourt, France; Centre ChronoS, GHU Paris - Psychiatry & Neurosciences, 1 rue Cabanis, 75014 Paris, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in The Neuroscientist
Verified
Journal Article
Closed access
ESEmilie Stern
Emilie Stern
JFJean-Arthur Micoulaud Franchi
Jean-Arthur Micoulaud Franchi
GDGuillaume Dumas
Guillaume Dumas
JMJeverson Moreira
Jeverson Moreira
MSmouchabac stephane
mouchabac stephane
PGPierre A. Geoffroy
Pierre A. Geoffroy
The use of digital technologies is constantly growing around the world. The wider-spread adoption of digital technologies and solutions in the daily clinical practice in psychiatry seems to be a question of when, not if. We propose a synthesis of the scientific literature on digital technologies in psychiatry and discuss the main aspects of its possible uses and interests in psychiatry according to three domains of influence that appeared to us: 1) assist and improve current care: digital psychiatry allows for more people to have access to care by simply being more accessible but also by being less stigmatized and more convenient; 2) develop new treatments: digital psychiatry allows for new treatments to be distributed via apps, and practical guidelines can reduce ethical challenges and increase the efficacy of digital tools; and 3) produce scientific and medical knowledge: digital technologies offer larger and more objective data collection, allowing for more detection and prevention of symptoms. Finally, ethical and efficacy issues remain, and some guidelines have been put forth on how to safely use these solutions and prepare for the future.

11 November 2023 in Psychiatry Research
Verified
Journal Article
Closed access
JMjulia maruani
julia maruani
CBCharlotte Boiret
Charlotte Boiret
JLJeanne Leseur
Jeanne Leseur
ARAlix Romier
Alix Romier
BBBalthazar Bazin
Balthazar Bazin
Pierre A. GeoffroyPierre A. Geoffroy
Pierre A. Geoffroy

4 October 2023 in Psychiatry Research
Verified
Journal Article
Closed access
JMjulia maruani
julia maruani
ESEmilie Stern
Emilie Stern
CBCharlotte Boiret
Charlotte Boiret
JLJeanne Leseur
Jeanne Leseur
ARAlix Romier
Alix Romier
Pierre A. GeoffroyPierre A. Geoffroy
Pierre A. Geoffroy

17 October 2023 in Journal of Sleep Research
Verified
Journal Article
Open access
Pierre A. GeoffroyPierre A. Geoffroy
Pierre A. Geoffroy
ESEmilie Stern
Emilie Stern
JMjulia maruani
julia maruani
RCRenaud Cornic
Renaud Cornic
BBBalthazar Bazin
Balthazar Bazin
CCCamille Couffignal
Camille Couffignal
Summary: This psychometric pilot study aims to evaluate a new multidimensional simple scale, named the nightmare severity index (NSI) – close to the existing insomnia (ISI) and hypersomnia (HSI) severity indexes. The NSI encompasses all main dimensions of nightmare disorder, evaluating four subdimensions: frequency, emotional impact, diurnal impact, and nocturnal impact of nightmares. The NSI was completed by a total of 102 patients. The majority of the population consisted of women (64%) and outpatient individuals (76%) diagnosed with mood disorders such as depression (31%) and bipolar disorder (41%). Comorbidity with post‐traumatic stress disorder (PTSD) was prevalent (44%), and psychotropic medications were commonly used (47%). Internal validity analyses indicated that the NSI was well suited for exploratory factor analysis. All items demonstrated satisfactory correlations with the factors, and the questionnaire exhibited good internal consistency (Cronbach's alpha >0.7). Higher NSI scores were observed among individuals experiencing nightmare symptoms considering the DSM‐5/ICSD‐3 criteria. In summary, the NSI proves to be a promising and valuable tool for clinical practice, demonstrating good acceptability, internal validity, and the ability to assess nightmare severity.

20 February 2024 in Psychiatry Research
Verified
Journal Article
Closed access
JLJeanne Leseur
Jeanne Leseur
CBCharlotte Boiret
Charlotte Boiret
ARAlix Romier
Alix Romier
BBBalthazar Bazin
Balthazar Bazin
LBLouise Basquin
Louise Basquin
JMjulia maruani
julia maruani

8 May 2024 in L'Encéphale
Verified
Journal Article
Open access
ESEmilie Stern
Emilie Stern
ZBZélia Breton
Zélia Breton
MAMaïa Alexaline
Maïa Alexaline
PGPierre A. Geoffroy
Pierre A. Geoffroy
CBCatherine Bungener
Catherine Bungener
Digital therapeutic programs are emerging almost daily, offering the potential to reduce healthcare access inequalities by providing more flexible and accessible care options. However, as with traditional healthcare, the issue of patient engagement is fundamental, and the latest research have reported that fewer than 30% of users complete these programs in their entirety. Hence, many authors emphasize the importance of studying the role of therapeutic alliances specifically adapted to digital care. The therapeutic alliance encompasses the collaborative aspects of the relationship between the therapist and the patient. In this context there is a need to reconceptualize the alliance within the context of digital healthcare as it can enhance engagement, adherence, and the effectiveness of such treatments. The objective of this qualitative study was to identify the components of the digital therapeutic alliance. A thematic analysis has identified three major themes that appear to constitute the digital therapeutic alliance among 44 users of an online program: trust in the program, perception of interactions, and feeling of consideration. These results prompted a discussion of the challenges of digital healthcare, including the terminology to use. The term "digital therapeutic adherence" is proposed, thereby opening up a field for research and clarification of this important concept distinct from traditional alliance.